So what is going on? Divisionally Fabric Care, Grooming and Baby/Family Care had net positive volume/price but overall it was a rather dull set of number...until you get to the foreign exchange line.
| October – December 2014 | Foreign | Organic | Organic | |||||||||||||||||||||
| Net Sales Drivers | Volume | Exchange | Price | Mix | Other* | Net Sales | Volume | Sales | ||||||||||||||||
| Beauty, Hair and Personal Care | -2 | % | -4 | % | 1 | % | 0 | % | -1 | % | -6 | % | -2 | % | -1 | % | ||||||||
| Grooming | -2 | % | -7 | % | 4 | % | 0 | % | 0 | % | -5 | % | -2 | % | 2 | % | ||||||||
| Health Care | -2 | % | -4 | % | 0 | % | 3 | % | 0 | % | -3 | % | -2 | % | 1 | % | ||||||||
| Fabric Care and Home Care | 2 | % | -6 | % | 1 | % | 0 | % | -1 | % | -4 | % | 2 | % | 3 | % | ||||||||
| Baby, Feminine and Family Care | 0 | % | -6 | % | 1 | % | 3 | % | 0 | % | -2 | % | 0 | % | 4 | % | ||||||||
| Total P&G | 0 | % | -5 | % | 1 | % | 1 | % | -1 | % | -4 | % | 0 | % | 2 | % | ||||||||
To get a feel for the impact take a look at the Q2 FY15 (the three month period just reported on) in currency neutral terms...
...and then in headline terms:
That is quite a difference and testimony to the strong US dollar influences I have noted multiple times recently (including earlier today in my United Technologies write-up here).
So how about FY15? Well it drags down that core EPS line again (the 'all-in' and 'constant $' measures are more volatile due to divestments and related)...
...but at least the company is returning money to shareholders. Using the mid-point of the share repurchase guidance this equates to a return to shareholders of around 5.6% of the current market cap (just over half being paid out in a dividend).
So with the income friendly aspect still established, what about the capital growth biased investor? With the shares trading at around high x14s EV/ebit for their FY15e, a more reasonable entry point would be sub x14 EV/ebit or a share price around US$83.
Interestingly this is a level which has shown some resistance/support at a couple of points over the last year.
This is the level I have noted down.






The utmost bullish viewpoint for the p&g stock is given by Credit Suisse research firm analyst Michael Steib. The $105 target price mentioned by the analyst is the highest by any research analyst. Conversely, Eane BNP Paribas analyst Mr. Jeff Stent has given the lowest price target of $83 to Proctor & Gamble Co (PG).
ReplyDelete